Hong Kong · Delayed Price · Currency is HKD Beijing Luzhu Biotechnology Company Description
Beijing Luzhu Biotechnology Co., Ltd., a biotechnology company, develops human vaccines and therapeutic biologics to prevent and control infectious diseases, and to treat cancer and autoimmune diseases in Mainland China.
The company is developing LZ901, a recombinant herpes zoster vaccine for which a biologics license application (BLA) has been submitted; K3, a recombinant human anti-tumor necrosis factor-alpha monoclonal antibody injection that has completed a Phase 1 clinical trial for the treatment of autoimmune diseases, such as rheumatoid arthritis, ankylosing spondylitis, and plaque psoriasis; and K193, a bispecific antibody injection in a Phase 1 clinical trial for the treatment of B cell leukemia and lymphoma.
Its preclinical-stage product candidates comprise a recombinant varicella vaccine for the prevention of varicella in children; a recombinant syncytial virus (RSV) vaccine for RSV-induced lower respiratory tract disease; a recombinant HSV-1 vaccine that targets oral herpes or cold sores; a recombinant HSV-2 vaccine that targets genital herpes; K333, a bispecific antibody injection product for the treatment of myeloid leukemia; and K1932, a bispecific antibody to treat b cell lymphoma.
In addition, the company offers immunoreagents, such as Group A meningococcal polysaccharide IgG, Group C meningococcal polysaccharide IgG, Group Y meningococcal polysaccharide IgG, Group W135 meningococcal polysaccharide IgG, and Haemophilus influenzae Type B polysaccharide IgG antibody detection kits; varicella-zoster virus antibody ELISA testing kits; and varicella-zoster virus antigen slides.
Beijing Luzhu Biotechnology Co., Ltd. was incorporated in 2001 and is headquartered in Beijing, China.
| Country | China |
| Founded | 2001 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 193 |
| CEO | Jian Kong |
Contact Details
Address: No. 3 Guangtong Street Beijing China | |
| Phone | 86 10 6156 8561 |
| Website | luzhubiotech.com |
Stock Details
| Ticker Symbol | 2480 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100005YD8 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Jian Kong | Co-Founder, GM, Chief Executive Officer, Chief Scientist and Chairman |
| Ling Peng | Executive Vice Chairperson and Deputy GM |
| Xianmin Jiang | Co-Founder, Deputy GM and Chief Medical Officer |
| Yanping Zhang | Co-Founder, Deputy GM and Executive Director |
| Zheng Liu | Chief Financial Officer |
| Chaowei Han | Head of Manufacturing and Engineering |
| Siyu Liu | Secretary of Board and Joint Company Secretary |
| Ho Yan Lai | Joint Company Secretary |